Načítá se...
Drug-eluting balloon: Initial experience in patients with in-stent restenosis (ISR)
BACKGROUND: In-stent restenosis is the most important limitation of modern coronary angioplasty. Drug-eluting stents solve this problem but at the cost of late stent thrombosis and longer duration of dual-antiplatelet therapy. Drug-eluting balloon (DEB) technology is now available and offers an attr...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4213889/ https://ncbi.nlm.nih.gov/pubmed/25378777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2014.01.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|